Frontage Holdings Corporation (OTC: FTHCY)
|
|
---|---|
Pricing data not available |
Open: | $ n/a | Volume: | n/a | |
---|---|---|---|---|
High: | $ n/a | Yield(%) | n/a | |
Low: | $ n/a | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | n/a |
---|---|
% Price Change (last 13 weeks): | n/a |
% Price Change (last 26 weeks): | n/a |
% Price Change (last 52 weeks): | n/a |
% Price Change (year to date): | n/a |
Return on Equity (%): | n/a |
---|---|
Return on Assets (%): | n/a |
Return on Invested Capital (%): | n/a |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | n/a |
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. It operates through the USA and PRC segments. The USA segment includes the bioanalytical, chemistry, manufacturing and controls (CMC), drug metabolism and pharmacokinetic (DMPK), and safety and toxicology services in the USA. The PRC segment covers the bioanalytical and bioequivalence services. The company was founded by Song Li in 2001 and is headquartered in Exton, PA.
|
Frontage Holdings Corporation
700 Pennsylvania Drive Exton PA 19341 Phone: 1.610.232.0100 Fax: 610.232.0101 http://www.frontagelab.com |
Earnings (1year) ($): | 0.09 |
---|---|
Annual Dividend ($): | n/a |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | n/a |
Cash Flow ($): | n/a |
Price/Earnings (x): | 22.05 |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | n/a |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | n/a |
---|---|
Current Ratio (x): | n/a |
LT Debt/Equity (x): | n/a |
Total Debt/Equity (x): | n/a |